Cornerstone Investment Partners’s Pfizer PFE Stock Holding History

Cornerstone Investment Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-138,701	Closed	-$4.3M	–	186
2020 Q2	$4.3M	Sell	138,701 -1,378,548	-91%	-$46.8M	0.31%	33
2020 Q1	$47M	Buy	1,517,249 +3,648	+0.2%	+$124K	3.03%	16
2019 Q4	$56.3M	Sell	1,513,601 -173,923	-10%	-$6.19M	2.67%	20
2019 Q3	$57.5M	Sell	1,687,524 -27,136	-2%	-$987K	2.53%	23
2019 Q2	$70.5M	Sell	1,714,660 -13,901	-0.8%	-$552K	3.06%	20
2019 Q1	$69.7M	Sell	1,728,561 -377,283	-18%	-$15.1M	3.1%	15
2018 Q4	$87.2M	Sell	2,105,844 -43,355	-2%	-$1.8M	4.26%	4
2018 Q3	$89.9M	Sell	2,149,199 -3,984	-0.2%	-$153K	3.77%	7
2018 Q2	$74.1M	Sell	2,153,183 -66,807	-3%	-$2.28M	3.35%	16
2018 Q1	$74.8M	Buy	2,219,990 +549,618	+33%	+$18.9M	3.27%	16
2017 Q4	$57.4M	Buy	1,670,372 +56,634	+4%	+$1.93M	2.5%	23
2017 Q3	$54.7M	Buy	+1,613,738	New	+$51.9M	2.39%	25

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cornerstone Investment Partners's PFE Position: Q3 2020 in Review

Cornerstone Investment Partners sold out of Pfizer (PFE) in Q3 2020, closing a stake of 138,701 shares — an estimated $4.3M sold.

Cornerstone Investment Partners first reported a position in PFE in Q3 2017 and held it in 12 quarters. The position peaked at $89.9M in Q3 2018. 2,508 funds tracked by Wall St. Rank hold PFE as of Q3 2020.

Cornerstone Investment Partners reported no remaining Pfizer position as of Q3 2020 after selling out during the quarter.
Cornerstone Investment Partners sold 138,701 Pfizer shares in Q3 2020, an estimated $4.3M.
Cornerstone Investment Partners first reported a position in Pfizer in Q3 2017 and held it in 12 quarters.
Cornerstone Investment Partners's Pfizer position peaked at $89.9M in Q3 2018.
2,508 funds tracked by Wall St. Rank held Pfizer as of Q3 2020.

Based on Cornerstone Investment Partners's 13F filing for Q3 2020, filed 30 Oct 2020.